(Date:7/2/2009)...tistical and biological issues need to be addresse... early detection of cancer, according to a comment... National Cancer Institute . , The biomarker pip...ts includes the identification of promising biomar...efinitive evaluation of biomarkers for cancer scre...
(Date:7/2/2009)...ncer patients who receive brachytherapy and remain...ikely to have a recurrence at 10 years, according ...al Journal of Radiation Oncology*Biology*Physics ,...Radiation Oncology (ASTRO)., Brachytherapy is the...to a tumor either permanently or temporarily, depe...
(Date:7/2/2009)...n urged for youngsters taking common antibacterial...Day News) -- A common antibacterial treatment for ...ss, finds a new study. , Researchers reviewed t...treated over a 13-year period at Children,s Hospit...m suffered from sensorineural hearing loss. Of tho...
(Date:7/2/2009)...hio, July 2 Cardinal Hea... the company,s board of directors effective upon t... Corporation, replacing John B. McCoy who has reti...ears of service to the company as a director. ,...tive officer of Barr Pharmaceuticals, Inc. and pas...
Breaking Medicine News(10 mins):Health News:Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years 2...nother discovery to its credit. Magnetic Resonance...-surgical method of identifying brain infections s...way of diagnosing meningitis. The new method will ...r and other types of brain infection in a simple b...
...he Department of Veterans Affairs (VA) researchers...l levels and provided a guideline to do so.// High... and blood vessels, but they may also increase the..., which may lead to Alzheimer’s disease. During Se...
...epidemic continues to cause deaths in the state of...re tight-lipped about the toll in a Japanese encep... yesterday admitted the dreaded disease had claime...about 80 percent of them children, have died in Go...
...mergency room with cervical spinal injury may have...hich is published in the Annals of Emergency Medic...uch injuries in patients over and above the normal...tients with a cervical spinal injury (CSI) may har...
Other Medicine News:Health News:High Cholesterol Can Be Controlled By Screening And Prevention 216mm from Mid-Screw to Blunt Tips, Gently Curved Blades; overall length 120mm; Stainless Steel
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle.
Straight shaft; a 5mm platform with 0.3mm 1x2 teeth; In Titanium.
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium.
Medicine Products:
(Date:7/3/2009)...TURKU, Finland, July 3 BioCis Phar...y with its headquarters in Turku, Finland,announ...rial of ProtoCure(TM),emulsion cream, the company...e-blind, placebo-controlled study, conducted in Fi... atopic dermatitis who applied the ProtoCure,emul...
(Date:7/1/2009)...REYKJAVIK, Iceland, July 1 /PRNewswire-FirstCall/ ...enia ever undertaken has revealed several new comm...human genome (SNPs) linked to,risk of the disease...ntists,led by a team from deCODE genetics (Nasdaq...00 patients and control participants from fourteen...
(Date:6/30/2009)...DIEGO, June 30 Accumetrics, Inc. a...00 patients) in the enrollment of its landmark cli...with A V erifyNow(R) Assay I mpact on T hrombos...igned to demonstrate the value of providing clinic...are poor responders to clopidogrel (Plavix(R)). T...
(Date:6/29/2009)...pective Study Seeks to Assess RSV Burden in Outpat...g Commitment to Pediatric Research , , GAITHE...tinues to advance its commitment to pediatric rese...ational prospective study designed to assess the b...reterm infants 32-to-35 weeks gestational age (GA)...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Ten Finalists Chosen for 2007 Hutch Award 3606 1Ten Finalists Chosen for 2007 Hutch Award 3606 2FDA Approves Administration of LEXIVA 28R 29 with Lower Dose of Boosting Medication Ritonavir 1244 1FDA Approves Administration of LEXIVA 28R 29 with Lower Dose of Boosting Medication Ritonavir 1244 2FDA Approves Administration of LEXIVA 28R 29 with Lower Dose of Boosting Medication Ritonavir 1244 3FDA Approves Administration of LEXIVA 28R 29 with Lower Dose of Boosting Medication Ritonavir 1244 4US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 1US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 2US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 3ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 1ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 2ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 3ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 4ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 5ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 6ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 7ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 8ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 9ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 10ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 11ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 12ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 13ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 14ARIUS Announces Third Quarter Fiscal 2007 Financial Results 1242 15... WASHINGTON, DC, June 11, 2007 /PRNewswire-FirstCa...and Medicine at Georgetown,University Medical Cent...s of Neurochem Inc.,s North American Phase III cli...resent today an update on,Neurochem,s investigatio...er,s disease (AD). The presentation by Dr. Aisen w...
...~ Valopicitabine achieved both primary and seconda...action was observed between,valopicitabine and rib...ire-FirstCall/ -- Idenix,Pharmaceuticals, Inc. tod...d to evaluate triple combination therapy, consisti...andidate for the,treatment of hepatitis C, pegylat...
Other Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6